Want to join the conversation?
AJ Rice of UBS asks for an update on medical cost trends. $CI said it continues to build strong trend results and its outlook remains consistent with the full-year 2016 trend expected to be 4-5%. The company expects to deliver strong medical trends in the coming year and does not see any major changes to the underlying components.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.